The breach of contract claim survives, keeping the dispute alive. Monitor for discovery and potential settlement discussions. The $7.3 million alleged underpayment is small relative to Albertsons' scale, limiting material stock impact.
Price Chart
Executive Summary
The Delaware Superior Court partially granted Express Scripts' motion to dismiss in a contract dispute with Albertsons over drug classification and reconciliation payments. The court dismissed Albertsons' implied covenant of good faith and fair dealing claim (Count II) and unjust enrichment claim (Count III), finding the Provider Agreement governs the conduct. However, the breach of contract claim (Count I) survives because factual disputes over the contractual dispute procedure deadline cannot be resolved at the motion to dismiss stage. Albertsons alleges Express Scripts reclassified drugs from brand to generic at reconciliation, causing an underpayment of at least $7.3 million.
Court Ruling Details
Key Facts
- Albertsons sued Express Scripts over drug classification and reconciliation payments under Pharmacy Provider Agreements.
- Albertsons alleges Express Scripts reclassified drugs from brand to generic at annual reconciliation, causing an underpayment of at least $7.3 million.
- The court dismissed the implied covenant of good faith and fair dealing claim (Count II) and unjust enrichment claim (Count III).
- The breach of contract claim (Count I) survives because factual disputes over the contractual dispute procedure deadline cannot be resolved at this stage.
- Express Scripts owes Albertsons an additional $3,655,627 from the 2023 Year End Reports, which has not been paid.
- The ruling is interlocutory — the case continues on the breach of contract claim.
Financial Impact
Albertsons alleges at least $7.3 million in underpayment from drug reclassification; Express Scripts also owes $3,655,627 from the 2023 Year End Reports. No damages awarded in this ruling.
Risk Factors
- If Albertsons ultimately loses on the breach of contract claim, it may recover nothing beyond the undisputed $3.66 million.
- The implied covenant and unjust enrichment claims are dismissed, narrowing Albertsons' legal theories.
- Factual disputes over the dispute procedure deadline create uncertainty; a trial or summary judgment motion will determine if the claim is time-barred.
Investment Themes
Documents Analyzed
This report is based on 1 court opinion.
| Document | Accession Number |
|---|---|
| COURT-RULING Data (Synthetic) | court-6db2260775-ACI |
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Oct 21, 2026 5d ago | Institutional Cluster | $13.87 | awaiting T+20 | — | $13.96 (+0.65%) |
Oct 20, 2026 7d ago | Court Ruling | $13.20 | awaiting T+20 | — | $13.96 (+5.79%) |
Oct 16, 2026 10d ago | 3 | $12.98 | awaiting T+20 | — | $13.96 (+7.56%) |
Oct 15, 2026 11d ago | 8-K | $12.93 | awaiting T+20 | — | $13.96 (+7.97%) |
Oct 15, 2026 12d ago | Court Ruling | $12.93 | awaiting T+20 | — | $13.96 (+7.97%) |
Oct 13, 2026 13d ago | 8-K | $12.56 | awaiting T+20 | — | $13.96 (−11.11%) |
Sep 10, 2026 6w ago | 3 | $12.08 $12.19 | ▲ +0.91% | ▼ −0.96% | $13.96 (+15.56%) |
Sep 9, 2026 6w ago | 8-K | $11.85 $11.74 | ▼ −0.93% | ▼ −3.13% | $13.96 (+17.81%) |
Aug 26, 2026 8w ago | Court Ruling | $12.23 $11.67 | ▲ +4.58% | ▲ +4.61% | $13.96 (−14.15%) |
Aug 12, 2026 10w ago | Institutional Cluster | $12.01 $11.70 | ▲ +2.58% | ▲ +0.68% | $13.96 (−16.24%) |
US Market Status
Subscribe to SecBot
Get Real-Time Court Ruling Intelligence
Market-moving court rulings analyzed within minutes. Patent verdicts, antitrust decisions, class certifications, and more — parsed and scored by AI.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers